These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1455758)

  • 1. [Disorders of lipid metabolism in type 2 diabetics].
    Ivancová G; Tkácová R; Ivanco I
    Vnitr Lek; 1992 Aug; 38(8):759-63. PubMed ID: 1455758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum lipid levels in diabetic Papua New Guineans.
    Erasmus RT; Sinha AK; Gena M; Betuela I; Muthaiah AC; Nathaniel K
    P N G Med J; 1991 Mar; 34(1):17-21. PubMed ID: 2058298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors affecting serum lipid levels in patients with type 2 diabetes mellitus].
    Tkác I; Tkácová R; Molcányiová A; Mudríková T; Takác M
    Vnitr Lek; 1994 Jan; 40(1):17-20. PubMed ID: 8140744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of policosanol and lovastatin on lipid profile and lipid peroxidation in patients with dyslipidemia associated with type 2 diabetes mellitus.
    Castaño G; Menéndez R; Más R; Amor A; Fernández JL; González RL; Lezcay M; Alvarez E
    Int J Clin Pharmacol Res; 2002; 22(3-4):89-99. PubMed ID: 12837046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Disorders of lipid metabolism in 3 patients with diabetes mellitus type 2].
    Wolffenbuttel BH; Huijberts MS
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):761-5. PubMed ID: 11346911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disorders of lipid metabolism in diabetes mellitus].
    Biesenbach G
    Wien Med Wochenschr Suppl; 1989; 105():9-17. PubMed ID: 2694631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
    Kostić N; Secen S
    Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacologic treatment of type 2 diabetic dyslipidemia.
    Moon YS; Kashyap ML
    Pharmacotherapy; 2004 Dec; 24(12):1692-713. PubMed ID: 15585439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coronary risk and dyslipidemia in type 2 diabetic patients.
    Udawat H; Goyal RK; Maheshwari S
    J Assoc Physicians India; 2001 Oct; 49():970-3. PubMed ID: 11848328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of lipid abnormalities in Sri Lankan patients with non-insulin dependent diabetes mellitus.
    Siribaddana S; Perera N; Perera S; Fernando D; Weerasuriya N
    Ceylon Med J; 1994 Mar; 39(1):22-5. PubMed ID: 8194142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering effect of simvastatin in patients of type 2 diabetes mellitus.
    Udawat H; Goyal RK
    Indian Heart J; 2001; 53(2):172-6. PubMed ID: 11428472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
    Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
    Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of decreased serum adiponectin for type IIb hyperlipidaemia and increased cholesterol levels of very-low-density lipoprotein in type II diabetic patients.
    Yoshida H; Hirowatari Y; Kurosawa H; Tada N
    Clin Sci (Lond); 2005 Sep; 109(3):297-302. PubMed ID: 15907189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of hyperlipidemia in primary practise in Germany: sub-group analyses from the 4E-registry with particular emphasis on men and women with diabetes mellitus.
    Assmann G; Schulte H; Cullen P; Neiss A; Bestehorn K
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):85-91. PubMed ID: 17318766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of soybean D-LeciVita product on serum lipids and fatty acid composition in type 2 diabetic patients with hyperlipidemia.
    Ristić Medić D; Ristić V; Arsić A; Postić M; Ristić G; Blazencić Mladenović V; Tepsić J
    Nutr Metab Cardiovasc Dis; 2006 Sep; 16(6):395-404. PubMed ID: 16935698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of serum lipids and lipoproteins in Ethiopian diabetic patients.
    Seyoum B; Abdulkadir J; Berhanu P; Feleke Y; Mengistu Z; Worku Y; Ayana G
    Ethiop Med J; 2003 Jan; 41(1):1-8. PubMed ID: 12764995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Lipid disorders in non-insulin dependent diabetes--principles of treatment].
    Idzior-Waluś B
    Przegl Lek; 1996; 53(9):653-9. PubMed ID: 8992531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of obesity and hypertriglyceridaemia on the low HDL2-cholesterol level and on its relationship with prevalence of atherosclerosis in type 2 diabetes.
    Verges B; Brun JM; Vaillant G; Quantin C; Brunet-Lecomte P; Farnier M; Gambert P
    Diabete Metab; 1992; 18(4):289-97. PubMed ID: 1459317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetes and heart disease: a new strategy for managing lipid disorders.
    Garber AJ
    Geriatrics; 1993 Oct; 48(10):34-6, 39-41. PubMed ID: 8406050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.